Every time the NCAA loses another eligibility ruling this summer – and it has lost a lot of them – its statement ends the same way: with a plea for Congress to pass the Protect College Sports Act. This week, as the NFL-returnee fight escalated, that plea got louder, and the bill got its two most important endorsements yet: the SEC and the Big Ten.
The PCSA is the NCAA’s exit strategy from the courtroom. Its core provision would grant the organization antitrust immunity on eligibility matters – which would not so much win the current lawsuits as delete the legal theory they run on. That makes it the highest-stakes item in this entire saga, and also the slowest-moving one.
Here’s what the bill does, who’s behind it, and why its clock may matter more than its content.
What the Bill Actually Does
Among other provisions, the PCSA would grant the NCAA antitrust immunity on eligibility matters – meaning rules like the five-for-five model, and its exclusion of the 2022 class described in the Class of 2022 loophole, could not be attacked under the Sherman Act. Since nearly every athlete victory this summer runs on that antitrust theory, immunity would pull the foundation out from under the entire wave, including the Wisne class action.
Who’s Backing It
The coalition is unusually broad: the NCAA has championed it for months, with president Charlie Baker arguing that without congressional action the organization can’t set nationwide rules everyone plays by. The SEC and Big Ten announced support – a move seen as raising the odds of a Senate vote – and President Trump supports the bill. Passage would still require both the Senate and the House.
The Case Against It
Opponents’ argument is the mirror image: antitrust litigation is the tool that produced nearly every athlete-side gain of the past five years – NIL, transfer freedom, and now the fifth-year rulings. Grant immunity, they argue, and the mechanism that forced those changes disappears, leaving athletes’ interests to the same governance that created the Class of 2022 gap in the first place. This is a genuinely contested policy question, and it’s likely to be argued as loudly as the lawsuits themselves.
The Clock Problem
Whatever one thinks of the merits, the calendar is stubborn: even a fast-moving bill takes months, and college rosters for this season are being finalized now, by judges and transfer-portal deadlines. The PCSA can shape 2027 and beyond; the 2026 season belongs to the courts – and, this week, to the conference-ban fight.
Quick Answers
Would the PCSA end the current lawsuits?
It would remove their central antitrust theory going forward – the precise effect on cases already pending would itself become a litigated question.
Do other leagues have antitrust protections?
Targeted carve-outs exist elsewhere in American sports – most famously baseball’s judicially created exemption – which is part of why the NCAA frames this as ordinary rather than radical.
When could it pass?
No vote is scheduled publicly; reporting suggests the Senate would move first, with the endorsements improving those odds – and the House after that. Months, at best.
The Bottom Line
The Protect College Sports Act is a bipartisan bill that would grant the NCAA antitrust immunity on eligibility rules – ending the legal theory behind this summer’s athlete victories. The NCAA, SEC and Big Ten back it, the president supports it, and the Senate would act first. Its supporters call it the only path to uniform national rules; its critics call it the end of athletes’ best leverage; and its timeline means the 2026 season will be settled by judges either way.